DNAprint Genomics (DNAG)

[IVRT]

DNAPrint Adds Famous Biostatistician to Board of Advisors

November 22, 2000
SARASOTA, Fla., Nov 22, 2000 (BUSINESS WIRE) -- DNAPrint genomics, Inc. (Pink Sheets:DNAP) announced today that the company has added Professor DC Rao to its Scientific Advisory Board (SAB).
Dr. Rao currently serves as the Director of the Division of Biostatistics, at the Washington University in St. Louis (WUSTL). Dr. Rao has served in this role since 1980, and has been a Professor of Biostatistics since 1982. He holds joint appointments in the Departments of Psychiatry, Genetics, and Mathematics at Washington University. Additionally, Dr. Rao is a member and past president of the International Genetic Epidemiology Society (1996) and is a founding Editor-in-Chief of the society's journal, Genetic Epidemiology.

Dr. Rao is an expert in genetic epidemiology. His research in the field includes the development of new methods to analyze and model genetic data. Washington University is one of the handful of academic centers working on the Human Genome Project. His work at WUSTL focuses on the genetic dissection of complex disease traits such as coronary heart disease, obesity, hypertension, and pulmonary disease. As an experienced genetic epidemiologist, Dr. Rao is best known for his contributions to path analysis. He has published over 300 research articles in peer-reviewed journals and is considered to be one of the world's top Statistical Geneticists.

The Company recently announced the addition of another well-known Statistical Geneticist, Dr. Ponnuswamy, as a full-time Scientist and Vice-President of the Company's Department of Biostatistics. The addition of Dr. Rao to the companies SAB further strengthens the Companies expertise in this field.

About DNAPrint genomics

DNAPrint genomics, Inc. is developing complex genetic analytics and information resources for next generation personalized medicine. The company's products will provide practitioners of genomic research and personalized medicine with a comprehensive system for complex trait dissection and patient classification. DNAPrint genomics Inc. was founded by a group of scientists with research and commercial experience in high-level mathematical modeling, programming and molecular genetics. On November 3, 2000, the company announced that it had filed its form 8K and expects to be trading on the NASD OTC Bulletin Board in the next few weeks. For more information about the company, please visit www.DNAPrint.com.

All statements in this press release that are not historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.




CONTACT: DNAPrint genomics, Inc., Sarasota
For Scientific inquiries:
Tony Frudakis, Ph.D., 941/351-4543
or
Other inquiries
Richard Craig Hall, 941/341-0136

URL: http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.

Copyright (C) 2000 Business Wire. All rights reserved.